1. Stats
  2. USPTO
  3. TC 1600
  4. Group 1650
  5. Art Unit 1656
  6. Examiner Lee

Examiner Lee Jae W

1656-LEE-JAE-W

Employment Information

Art Unit:1656 — Chemistry: molecular biology and microbiology
Group:1650 — Enzymology, Microbiology, and Fermentation, Small Peptides and Bioacting Plant, Microbial and Animal Extracts
Classes: 435 — Chemistry: molecular biology and microbiology
424 — Drug, bio-affecting and body treating compositions
530 — Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
514 — Drug, bio-affecting and body treating compositions
506 — Combinatorial chemistry technology: method, library, apparatus
510 — Cleaning compositions for solid surfaces, auxiliary compositions therefor, or processes of preparing the compositions
536 — Organic compounds -- part of the class 532-570 series
702 — Data processing: measuring, calibrating, or testing
800 — Multicellular living organisms and unmodified parts thereof and related processes
204 — Chemistry: electrical and wave energy
Phone:(571) 272-9949
Email:jae.lee1@uspto.gov
Location:VA 22314
Title:Pat Examnr Phrmcolgy
Service:20 years
Grade:GS-13

Grant Rate and Difficulty Ranking

38
3-Year Grant rate: 83% over 321 cases
Difficulty: Easier
Difficulty Percentile: 38th

With Examiner Lee, you have a 83% chance of getting an issued patent by 3 years after the first office action. Examiner Lee is an easier examiner and in the 38th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Lee, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1656

Examiner Lee's grant rate is higher than that of Art Unit 1656 and higher than that of the USPTO.

Average Office Actions Per Grant
Examiner Lee 0.3
Art Unit 1656 1.4

Interview Benefit

Grant Rate without Interview

Examiner Lee has granted 251 of 302 cases without any applicant-requested interviews for a grant rate of 83%.

Grant Rate with Interview

Examiner Lee has granted 15 of 19 cases with at least one applicant-requested interview for a grant rate of 79%.

Interview Benefit

With Examiner Lee, conducting an interview decreases your chance of getting a patent granted by 5%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
18379079 Biological Production Of Multi-Carbon Compounds From Methane Rejection information available with a Premium Stats subscription. See our pricing. Patented View
18301790 Processes For The Production Of Tryptamines Patented View
18023891 Single-Chain Coronavirus Viral Membrane Protein Complexes Patented View
17638379 Compositions Comprising Decarboxylated Cannabinoids Patented View
18016440 Immunoglobulin Binding Proteins For Affinity Purification Patented View
17918835 Sars-Cov-2 Spike Receptor Binding Domain And Compositions And Methods Thereof Patented View
17758959 Anti-Dinitrophenol Chimeric Antigen Receptors Patented View
17878657 Recombinant Expression Platform, Constructs And Methods For Expression Of Difficult To Express Proteins (Dte-Ps) Patented View
17998543 Emid2 Protein As Anti-Cancer Treatment Abandoned View
17858364 Methods Of Treating Diseases And Conditions, Such As Inflammatory Diseases, Cancer, Cardiovascular Disease, Diabetes And Obesity With The Probiotic Lactobacillus Johnsonii 456 Abandoned View
17802018 Chimeric Receptors For Use In Engineered Cells Abandoned View
17810042 Compositions, Systems, And Methods For Genome Editing Patented View
17632739 Production Of Protein Solid Material Patented View
17810023 Compositions, Systems, And Methods For Genome Editing Patented View
17765921 Tissue Adhesion Composition With Bio-Tissue Adhesiveness And Bonding Force And Preparation Method Therefor Abandoned View
19328055 Prevention Of Disulfide Bond Reduction During Recombinant Production Of Polypeptides Patented View
17626482 Nanoparticle Systems For Targeted Delivery Of Crispr/cas13 And Methods Of Using Same Patented View
17670467 Dna Repair Blood Test For Predicting Response Of Lung Cancer Patients To Immunotherapy Patented View
18409535 Treatment Of Abnormal Bone Conditions In Acid Sphingomyelinase Deficiency Patients Abandoned View
17784796 Methods Of Enhancing And Expediting Expression Of Antibodies Abandoned View
17995794 Galectin-1 Immunomodulation And Myogenic Improvements In Muscle Diseases And Autoimmuine Disorders Abandoned View
18948388 Composition Comprising Collagenase, Calcium, Histidine, And Glycine, And Method For Stabilizing Collagenase Patented View
18021270 Engineered Polymerases And Methods Of Using The Same Patented View
17764925 Mnep Monomer Variant And Application Thereof Patented View
19212289 Stabilization Of Tryptamines By Denaturing Enzymes, Optimizing Ionization States, And Controlling Confounding Variables Patented View
19310812 Reverse Transcriptase Variants Patented View
18345783 Methods And Compositions For Improving Plant Traits Patented View
18048548 Compositions, Methods, And Applications Of A Synthetic Surfactant Patented View
17768359 Novel Protospacer Adjacent Motif Sequence And Method For Modifying Target Nucleic Acid In Genome Of Cell By Using Same Patented View
17786478 Methods And Compositions For High Efficiency Homologous Repair-Based Gene Editing Abandoned View
17737614 Cleaning Compositions And Uses Thereof Patented View
17920407 Highly Alkaline Textile Washing Agent Comprising Protease Patented View
18011785 Pro-Microbial Surface Patented View
18139481 Platform For Expressing Protein Of Interest In Liver Patented View
17930626 Compositions Of Anti-Viral Peptides And Methods Of Use Thereof Patented View
17634283 Method For Assessing Risk Of Cutaneous Adverse Drug Reactions Caused By Epidermal Growth Factor Receptor Inhibitors, Detection Kit Thereof, And Use Thereof Patented View
17698390 Tuning Crispr/cas9 Activity With Chemically Modified Nucleotide Substitutions Patented View
17677499 System And Method For Characterizing Drug Product Impurities Patented View
17761709 Tag Protein For Increasing Water Solubility And Heat Stability Of Target Protein, And Fusion Protein Comprising Same Patented View
17931352 Enzyme Based System For Production Of Messenger Rna With Increased Transfection Efficiency Patented View
18598286 Systems For Determining Adamts13 Enzyme Activity Patented View
17959089 Materials And Methods For Treatment Of Pain Related Disorders Patented View
18431554 Active Low Molecular Weight Variants Of Angiotensin Converting Enzyme 2 (Ace2) Abandoned View
18483460 Programmed Dna-Driven Self-Assembled Rna Hydrogel Abandoned View
17637710 Methods For Scalable Gene Insertions Abandoned View
18984162 Crispr/cas Screening Platform To Identify Genetic Modifiers Of Tau Seeding Or Aggregation Patented View
18472540 Ketoreductase Polypeptides For The Production Of Azetidinone Patented View
18595600 Alpha-Amylase Variants And Polynucleotides Encoding Same Patented View
17920410 Highly Alkaline Textile Detergent Comprising Protease Patented View
17812712 Chimeric Polypeptides Abandoned View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.